Evidence map›Paper›PMID 36760656›Full record

ArticleJournal of analytical methods in chemistry2023

A Novel Strategy for Screening Active Components in

Xiao-Tong Liu, Dong-Mei Sun, Wen-Xin Yu, Wei-Xiong Lin, Liao-Yuan Liu, Yu Zeng

Abstract read
In one paragraph

Article in Journal of analytical methods in chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Targeting collagen Prolyl 4-hydroxylase for cancer treatment.Medical oncology (Northwood, London, England) · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiao-Tong LiuSchool of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Dong-Mei SunGuangdong Provincial Key Laboratory of Traditional Chinese Medicine Formula Granule, Guangdong E-Fong Pharmaceutical Co. Ltd., Foshan 528244, China.
Wen-Xin YuSchool of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Wei-Xiong LinGuangdong Provincial Key Laboratory of Traditional Chinese Medicine Formula Granule, Guangdong E-Fong Pharmaceutical Co. Ltd., Foshan 528244, China.
Liao-Yuan LiuGuangdong Provincial Key Laboratory of Traditional Chinese Medicine Formula Granule, Guangdong E-Fong Pharmaceutical Co. Ltd., Foshan 528244, China.
Yu ZengSchool of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.ORCID https://orcid.org/0000-0003-4739-4994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36760656
PMCPMC9904937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.